Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

BACKGROUND: Factor Xa inhibitor is used for preventing venous thromboembolism (VTE) in adult patients receiving orthopedic operation. However, the role of factor Xa inhibitor, rivaroxaban, in angiogenesis is still unknown. METHODS AND RESULTS: Streptozotocin (STZ)–induced diabetic mice with model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tao-Cheng, Chan, Jenq-Shyong, Lee, Chiu-Yang, Leu, Hsin-Bang, Huang, Po-Hsun, Chen, Jia-Shiong, Lin, Shing-Jong, Chen, Jaw-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473833/
https://www.ncbi.nlm.nih.gov/pubmed/26077117
http://dx.doi.org/10.1186/s12933-015-0243-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473833/
https://www.ncbi.nlm.nih.gov/pubmed/26077117
http://dx.doi.org/10.1186/s12933-015-0243-y

Ejemplares similares